News

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to…
Read More...

Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) in…
Read More...

Neuroptika announced that the first patient was enrolled in a Phase 2 clinical trial of NRO-1 for the treatment of dry eye disease. NRO-1 is a novel therapeutic with the potential to…
Read More...

Twist Bioscience Corporation announced a collaboration with Schrödinger, Inc. to bring the two companies’ technology platforms together to discover new antibody therapeutics against…
Read More...

Azymus Therapeutics, an emerging pharmaceutical company, is advancing 10-years of nano-therapeutic research supported by its AZ Platform. The company's researchers are studying…
Read More...

Bayer and WuXi Biologics have entered into an agreement that WuXi Biologics Germany GmbH will take over operations of one of Bayer’s final drug product manufacturing plants in…
Read More...

Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has entered into exclusive licensing and supply agreements with Rockwell Medical Inc. (Rockwell),…
Read More...

NuMedii, Inc. announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis. The collaboration will bring together NuMedii's NM-001 asset…
Read More...

Artisan Bio, Inc., a stealth cell therapy engineering company, announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited for…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US announced that a supplemental New Drug Application for Lynparza (olaparib) in combination with bevacizumab has been accepted and granted…
Read More...

Galapagos NV and Fibrocor Therapeutics Inc. announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a…
Read More...

Clovis Oncology announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for Rubraca (rucaparib) and granted…
Read More...

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced that it has entered into a collaboration and license agreement with Japan Tobacco Inc. (JT) for…
Read More...

ASC Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Vigene Biosciences, a Maryland-based Contract Develop and Manufacturing…
Read More...

ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate. Founded in…
Read More...

My Green Lab announced a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability,…
Read More...

Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc, and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced that they have…
Read More...

MorphoSys AG and Incyte Corporation announced that the companies have entered into a collaboration and license agreement to further develop and commercialize MorphoSys' proprietary…
Read More...

Charles River announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together, Charles River and Takeda will launch multiple integrated programs…
Read More...

BioMotiv, a mission-driven pharma company part of The Harrington Project for discovery and development, and Atomwise, the leader in using artificial intelligence (AI) for small molecule…
Read More...